Whitepaper

Real-World Evidence & Diagnostics In Cancer: Filling The Gaps In Oncology Treatment
Testing the ability of Real-world data to address the essential questions in Oncology
REAL-WORLD EVIDENCE & DIAGNOSTICS IN CANCER: FILLING THE GAPS IN ONCOLOGY TREATMENT

More Whitepapers / Newsletters

HIV-Associated Lipodystrophy Market
HIV-Associated Lipodystrophy

HIV-associated lipodystrophy (HAL), is a condition characterized by the redistribution of adipose tissue. It can be due to several reasons, however, a significant amount of research done links its cau...

An Abundance Of Rare Newsletter
An Abundance Of Rare

Though appear rare, rare diseases are far from being rare. With over 7,000 rare disease affecting millions worldwide, Rare disease pose a huge burden on the global healthcare system, affecting the qua...

Adult Onset Still's Disease
Adult Onset Still's Disease

Affecting the entire body, Adult Onset Still's disease (AOSD) is a rare type of inflammatory arthritis that affects most people before the age of 45. The symptoms of the disease usually begin with a...

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Blastic Plasmacytoid Dendritic...

Blastic plasmacytoid dendritic cell neoplasm (BPDCN), an extremely rare form of neoplasm, generally affects the elderly male population. Cancer develops in bone marrow and blood. It involves multiple...

Remdesivir In COVID-19
Remdesivir In COVID-19

Remdesivir is a broad-spectrum antiviral drug that has previously demonstrated in vitro and in vivo activity against the viral pathogens MERS and SARS, which are also coronaviruses having structural s...